Peptide Therapy
Regeniq facilitates consultations between Australian men and AHPRA-registered practitioners. Every consultation starts with assessment, and a care plan is only considered once your history and pathology have been reviewed.
Six focus areas
Select an area to see what your practitioner assesses before any care plan is discussed.
Recovery and repair
Soft tissue and tendon complaints that settle more slowly than they used to, or training recovery that has stalled.
What the practitioner reviews
- Inflammatory markers
- Injury and training history
- Sleep quality and recovery windows
What a consultation involves
Assessment
You complete a clinical history covering symptoms, training, sleep, medications and prior investigations.
Pathology
Where indicated, your practitioner requests bloods so the consultation works from measured values rather than assumptions.
Consultation
A real-time video or phone consultation with an AHPRA-registered practitioner who reads the results with you.
Ongoing review
If a care plan is appropriate, it is reviewed at set intervals and adjusted against repeat pathology.
The case for a regulated pathway
Peptides are sold to Australian men every day through overseas websites and grey-market imports. No consultation, no pathology, no prescription, and no visibility of how the product was made, stored or shipped. The demand is real. The oversight is not.
Regeniq was built to be the opposite of that. Consultations are with AHPRA-registered practitioners. Assessment and pathology come first, a care plan is only considered once your results have been reviewed, and if one is not clinically appropriate your practitioner will tell you so.
That is what a regulated, practitioner-led pathway means: clinicians accountable to their regulator, telehealth that meets Medical Board requirements, and care reviewed against repeat pathology over time. Regeniq facilitates the consultation. Every clinical decision belongs to the practitioner.
Eligibility
Suitability is determined by an AHPRA-registered practitioner during a real-time consultation, in line with Medical Board telehealth requirements. Regeniq does not prescribe, diagnose, compound or dispense. Individual results may vary.